NovaBridge Biosciences (NBP) has outlined a series of near-term catalysts across its oncology and ophthalmology programs, positioning the company for multiple data readouts and conference presentations in 2026 and 2027.The company's pipeline includes Givastomig, VIS-101, Ragistomig, and Uliledlimab, each advancing in clinical development with anticipated milestones ahead.-- Givastomig, a Claudin 1...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.